论文部分内容阅读
目的观察中医药三期分治序贯治疗法防治小儿支气管哮喘的效果。方法选择我院2014年1月~2016年1月收治的110例支气管哮喘患儿作为研究对象,将两组随机平均分为观察组和对照组,对照组接受两期分治,观察组接受三期分治序贯疗法,比较两组患者的远期疗效、哮喘复发等情况。结果观察组近期治疗的有效率是96.4%,对照组的近期治疗有效率是90.9%,两组对比无显著差异(P>0.05);观察组的远期治疗有效为94.5%,对照组的远期治疗有效率是74.5%,两组比较差异显著(P<0.05),两组患者在治疗后的喘息和肺部哮鸣音消失的时间比较上无统计学意义(P>0.05),但是两组患儿在治疗后的第1秒用力呼气量(FEV1)、用力肺活量(FVC)比较差异十分明显(P<0.05)。结论中医药三期分治序贯疗法在防治小儿支气管哮喘方面具有安全可靠的治疗优势,并且可以帮助减少复发率,具有临床推广价值。
Objective To observe the effect of sequential therapy of traditional Chinese medicine (TCM) on prevention and treatment of bronchial asthma in children. Methods A total of 110 children with bronchial asthma admitted to our hospital from January 2014 to January 2016 were selected as the research object. The two groups were randomly divided into observation group and control group. The control group received two periods of treatment. The observation group received three Period sequential therapy, comparing the long-term efficacy of the two groups of patients, asthma recurrence and so on. Results The effective rate of short-term treatment was 96.4% in the observation group and 90.9% in the control group, with no significant difference between the two groups (P> 0.05). The long-term treatment effective rate in the observation group was 94.5% The effective rate of treatment was 74.5%, there was significant difference between the two groups (P <0.05). There was no significant difference between the two groups in the time of wheezing and pulmonary wheeze disappeared (P> 0.05) The forced expiratory volume (FEV1) and forced vital capacity (FVC) of the children in the group after treatment were significantly different (P <0.05). Conclusion The three-phase sequential therapy of traditional Chinese medicine has safe and reliable treatment advantages in the prevention and treatment of pediatric bronchial asthma, and can help reduce the recurrence rate, with clinical promotion value.